The drug only melts the fat deep inside the belly, not the fat you can pinch on the skin or in the arms and legs.
Scientific Claim
Tesamorelin selectively reduces visceral adipose tissue without affecting subcutaneous abdominal or limb fat in HIV-infected adults on antiretroviral therapy with abdominal fat accumulation, indicating tissue-specific action.
Original Statement
“Trunk fat (P < 0.001), waist circumference (P = 0.02), and waist-hip-ratio (P = 0.001) improved, with no change in limb or abdominal SC fat.”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
The study used precise body composition measurements and demonstrated selective effect with statistical significance, justifying definitive causal language.
Evidence from Studies
Supporting (1)
Unknown Title
Tesamorelin helped HIV patients lose belly fat deep inside their abdomen without shrinking fat in their arms, legs, or just under the skin, showing it targets only the bad belly fat.